Tufts University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Tufts University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013578
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tufts University (Tufts) is an educational and research university that offers undergraduate and postgraduate courses in various fields. The university offer courses in anthropology, applied mathematics, architectural engineering, physics, archaeology, Asian American studies, biochemistry, biomedical engineering, economics, child study and human development, cognitive and brain sciences, food systems and nutrition, geological sciences, philosophy, medieval studies, music and political science among others. It works with other institutes to conduct research on antibiotic resistance, cholera, HIV and lyme disease, and other pressing health issues. Tufts undertakes technology transfer for commercial development. It operates through various schools and colleges located across Massachusetts, the US. Tufts University is headquartered in Medford, Massachusetts, the US.

Tufts University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tufts University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tufts University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tufts University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tufts University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Tufts University, Medical Devices Deals, 2011 to YTD 2017 9
Tufts University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Tufts University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Tracon Pharma Enters into Research Agreement with Tufts Medical Center 11
Tufts Medical Center to Form Joint Venture with Lowell General Hospital 13
Tufts Medical Center Forms Joint Venture with Aton Partners 14
Pepticom Enters into Co-Development Agreement with Tufts Medical Center 15
Tufts Medical Center, Vanguard Health And New England Quality Care Partner For New Healthcare System 16
Licensing Agreements 17
Arisaph Pharma Enters into Licensing Agreement with Tufts University 17
GliaCure Enters into Licensing Agreement with Tufts University 18
Debt Offering 19
Tufts Medical Center Announces Public Offering Of Bonds For US$100 Million 19
Tufts University – Key Competitors 20
Tufts University – Key Employees 21
Tufts University – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Government and Public Interest 23
Sep 13, 2016: New technique generates human neural stem cells for tissue engineering, 3D brain models 23
Apr 12, 2016: Scientists reveal new target for anti-lymphangiogenesis drugs 24
Mar 16, 2016: Researchers Prevent, Normalize Tumors Using Light to Control Cell Electric Signals 25
Feb 10, 2016: Faulty bioelectric signal responsible for facial defects caused by rare genetic disorder 26
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Tufts University, Pharmaceuticals & Healthcare, Key Facts 2
Tufts University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tufts University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tufts University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tufts University, Deals By Therapy Area, 2011 to YTD 2017 8
Tufts University, Medical Devices Deals, 2011 to YTD 2017 9
Tufts University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Tracon Pharma Enters into Research Agreement with Tufts Medical Center 11
Tufts Medical Center to Form Joint Venture with Lowell General Hospital 13
Tufts Medical Center Forms Joint Venture with Aton Partners 14
Pepticom Enters into Co-Development Agreement with Tufts Medical Center 15
Tufts Medical Center, Vanguard Health And New England Quality Care Partner For New Healthcare System 16
Arisaph Pharma Enters into Licensing Agreement with Tufts University 17
GliaCure Enters into Licensing Agreement with Tufts University 18
Tufts Medical Center Announces Public Offering Of Bonds For US$100 Million 19
Tufts University, Key Competitors 20
Tufts University, Key Employees 21
Tufts University, Subsidiaries 22

★海外企業調査レポート[Tufts University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Interferie S.A.:企業の戦略・SWOT・財務情報
    Interferie S.A. - Strategy, SWOT and Corporate Finance Report Summary Interferie S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • ASB Bank Limited:企業の戦略・SWOT・財務情報
    ASB Bank Limited - Strategy, SWOT and Corporate Finance Report Summary ASB Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Co-Diagnostics Inc (CODX):企業の製品パイプライン分析
    Summary Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit …
  • PT Kimia Farma (Persero) Tbk (KAEF):製薬・医療:M&Aディール及び事業提携情報
    Summary PT Kimia Farma (Persero) Tbk (Kimia Farma) manufactures, commercializes and distributes pharmaceutical products. The company provides ethical (prescription), generic and other products. It offers products in various categories including alimentary system, allergy and immune system, system an …
  • Catholic Health Initiatives:企業の戦略的SWOT分析
    Catholic Health Initiatives - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • ALLETE Inc (ALE):電力:M&Aディール及び事業提携情報
    Summary ALLETE Inc (ALLETE) is an energy company. It has interests in mining facilities; electricity generation, transmission, and distribution assets; and water management businesses. The company generates electricity using coal, natural gas, biomass, hydro, wind, and solar; and procures energy thr …
  • Cynosure Inc (CYNO)-医療機器分野:企業M&A・提携分析
    Summary Cynosure Inc (Cynosure) develops, manufactures and markets aesthetic and medical treatment systems. The company’s light-based aesthetic treatment systems are used in the treatment of skin revitalization and scar reduction, hair removal, gynecology, pigmentation, tattoo removal, wrinkle reduc …
  • I-Sens Inc (099190):企業の製品パイプライン分析2018
    Summary I-Sens Inc (I-SENS) is a medical device company that develops and distributes blood glucose monitoring systems. The company’s products comprise electrolyte and gas analyzers, blood glucose monitoring systems, immuno sensors and accessories, among others. It provides its blood monitoring syst …
  • Caladrius Biosciences Inc (CLBS):医療機器:M&Aディール及び事業提携情報
    Summary Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc, is a clinical-stage biopharmaceutical company that develops cell therapy products. The company offers multiple technology platforms targeting cardiovascular indications and autoimmune diseases. The company’s lead product CLBS03 is …
  • Stanbic IBTC Holdings Plc:企業の戦略・SWOT・財務情報
    Stanbic IBTC Holdings Plc - Strategy, SWOT and Corporate Finance Report Summary Stanbic IBTC Holdings Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • LCH.Clearnet Group Limited:企業の戦略・SWOT・財務情報
    LCH.Clearnet Group Limited - Strategy, SWOT and Corporate Finance Report Summary LCH.Clearnet Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ohr Pharmaceutical Inc (OHRP):企業の財務・戦略的SWOT分析
    Summary Ohr Pharmaceutical Inc (Ohr), formerly BBM Holdings Inc, is a pharmaceutical company that develops novel therapies for ophthalmic diseases. The company offers products such as squalamine lactate ophthalmic solution and SKS sustained release technology products. Its squalamine lactate ophthal …
  • The North West Company Inc. (NWC):企業の財務・戦略的SWOT分析
    The North West Company Inc. (NWC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Aero Components Inc.:企業の戦略・SWOT・財務情報
    Aero Components Inc. - Strategy, SWOT and Corporate Finance Report Summary Aero Components Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • China National Biotec Group-製薬・医療分野:企業M&A・提携分析
    Summary China National Biotec Group (CNBG), a subsidiary of China National Pharmaceutical Group Corp is a manufacturer and distributor of vaccines, therapeutic products and diagnostic reagents. The company develops biological products for disease prevention, therapeutic and diagnostic use. Its produ …
  • RRB Energy Ltd:企業の戦略的SWOT分析
    RRB Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Nascent Biotech Inc (NBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Nascent Biotech Inc (Nascent) is a clinical-stage biopharmaceutical company. The company delivers human monoclonal antibodies and cytokine for the treatment of cancer and drug discovery platform for identifying new antibodies and antigens for commercialization. It develops Pritumumab, a mono …
  • National Fuel Gas Co (NFG):企業の財務・戦略的SWOT分析
    National Fuel Gas Co (NFG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • HeartSine Technologies LLC:企業の戦略的SWOT分析
    HeartSine Technologies LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Bullet Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Bullet Biotechnology Inc (Bullet Biotechnology) focuses on the development of immunotherapies for the treatment of cancer. The company’s lead product, BB-006 is under development which is being developed to treat solid tumors. Bullet Biotechnology’s primarily interest in is immuno-oncology a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆